First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
Christoph Rageth(Hôpital Beau-Séjour), Zsuzsanna Varga(Zurich Heart House), Elizabeth A. Morris(University of California Davis Medical Center), Thomas Decker, G Kampmann, Christopher Comstock(Memorial Sloan Kettering Cancer Center), Stefanie Hosch(Immunologie-Zentrum Zürich), Elizabeth O’Flynn(Institute of Cancer Research), H. Madjar(Helios Kliniken), Jean-François Delaloye(University Hospital of Lausanne), Claudia Kurtz(Luzerner Kantonsspital), Astrid Baege(Immunologie-Zentrum Zürich), Domenico Lepori(Centre d'Imagerie BioMedicale), Christoph Tausch(Breast Center), Alexander Mundinger
Cited by 264
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse
|Osteoarthritis and Cartilage|2007|1.5k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991